When a gallbladder polypoid lesion measures 5 mm or less and the patient has no risk factors for malignancy, the clinical situation calls for a defined, evidence-based response. The structured protocol specifies the pathway for this presentation.
The patient has a gallbladder polypoid lesion of 5 mm or less and no identifiable risk factors for malignancy. Polyp diameter is the key stratifying measurement in this scenario.
For this low-risk presentation, the protocol outlines a specific, size-guided management pathway. The full recommendation — including what is and is not indicated — is available in the structured protocol below.
If the patient has no risk factors for malignancy, and a gallbladder polypoid lesion of 5 mm or less, follow-up is not required.
DOI: 10.1007/s00330-021-08384-w
View source ↗